Reply to the Editor

Pulmonary Artery Perforation by Plug Anchoring System After Percutaneous Closure of Left Appendage

Reply to the Editor

Malignant left atrial appendage morphology and embolization risk in atrial fibrillation

Commentary: The appendage strikes back: The last surgeon

Successful Percutaneous Left Atrial Appendage Closure in the Presence of a Nonobstructive Appendage Membrane

Comparison of Transesophageal Echocardiography Versus Computed Tomography for Detection of Left Atrial Appendage Filling Defect (Thrombus)

Left Atrial Appendage Inversion Presenting as Acute Right Ventricular Failure after Left Ventricular Assist Device Implantation

Left Atrial Reduction Plasty: A Novel Technique

An unusual intraoperative finding: Left atrial dissecting intramural hematoma after aortic root replacement.

Key Findings▪Percutaneous left atrial appendage (LAA) occlusion has emerged as an alternative strategy to oral anticoagulants in selected patients with atrial fibrillation.▪The landmark trials comparing LAA occlusion to an oral anticoagulation strategy enrolled patients with no apparent contraindications to the use of warfarin.▪LAA occlusion has limited head-to-head comparison against the direct-acting oral anticoagulants.▪Observational data to date have generally shown specific adverse events after LAA occlusion in specific subgroups of patients (women, patients with kidney disease and heart failure, patients belonging to racial/ethnic subgroups and with advanced age), but further large-scale studies are necessary to elucidate reasons for increased adverse events associated with LAA occlusion in these subgroups of patients before recommending this modality as first-line therapy in all patient groups. ▪Percutaneous left atrial appendage (LAA) occlusion has emerged as an alternative strategy to oral anticoagulants in selected patients with atrial fibrillation.▪The landmark trials comparing LAA occlusion to an oral anticoagulation strategy enrolled patients with no apparent contraindications to the use of warfarin.▪LAA occlusion has limited head-to-head comparison against the direct-acting oral anticoagulants.▪Observational data to date have generally shown specific adverse events after LAA occlusion in specific subgroups of patients (women, patients with kidney disease and heart failure, patients belonging to racial/ethnic subgroups and with advanced age), but further large-scale studies are necessary to elucidate reasons for increased adverse events associated with LAA occlusion in these subgroups of patients before recommending this modality as first-line therapy in all patient groups.

Pseudomyxoma Originating from the Interatrial Septum in a Heart Transplant Patient

Robotic-assisted biatrial Cox-maze ablation for atrial fibrillation

Catheter ablation for persistent atrial fibrillation in an elderly patient with cor triatriatum sinister

Wide-area antral pulmonary vein and posterior wall isolation by way of segmental nonocclusive applications using a novel radiofrequency ablation balloon

A novel ablation strategy for refractory atrial fibrillation based on the fractionated signal area in the atrial muscle